Results for tag: "Klebsiella Pneumoniae Drug"

Klebsiella Pneumoniae is a type of bacteria that can cause a range of infections, including pneumonia, urinary tract infections, and bloodstream infections. Infectious Diseases Drugs are used to treat these infections, and the Klebsiella Pneumoniae Drug market is a subset of this larger market. These drugs are typically antibiotics, which are used to kill or inhibit the growth of bacteria. They can be administered orally, intravenously, or topically, depending on the severity of the infection. The Klebsiella Pneumoniae Drug market is highly competitive, with many companies offering a range of products. Some of the major players in the market include Pfizer, Merck, GlaxoSmithKline, Sanofi, and AstraZeneca. Other companies, such as Novartis, Johnson & Johnson, and Bayer, also offer products in this market. Show Less Read more